ONCT - Oncternal Therapeutics Inc. (ONCT) CEO Jim Breitmeyer on Q4 2020 Results - Earnings Call Transcript
Oncternal Therapeutics, Inc. (ONCT) Q4 2020 Earnings Conference Call March 11, 2021, 05:00 PM ET Company Participants Richard Vincent - Chief Financial Officer Jim Breitmeyer - President & Chief Executive Officer Edwina Baskin-Bey - Acting Chief Medical Officer Conference Call Participants Carl Byrnes - Northland Securities Presentation Operator Greetings, and welcome to Oncternal's Therapeutics Incorporated Fourth Quarter 2020 Financial Results Call. [Operator Instructions] As a reminder this conference is being recorded. It is now my pleasure to introduce your host Richard Vincent, Chief Financial Officer of Oncternal Therapeutics. Thank you sir. You may begin. Richard Vincent Thank you, Victor. Good afternoon, everyone, and thank you for joining us today. Joining me on the call this afternoon are our President and CEO, Dr. James Breitmeyer; and Acting Chief Medical Officer, Dr. Edwina Baskin-Bey who has been working with us as a consultant for the past several months. We welcome all of
For further details see:
Oncternal Therapeutics, Inc. (ONCT) CEO Jim Breitmeyer on Q4 2020 Results - Earnings Call Transcript